Homebiopharmaceutical

biopharmaceutical

Moderna Stock Gains on Positive Data From the Phase III RSV Jab Study

Moderna Stock Gains on Positive Data From the Phase III RSV Jab Study

January 18, 2023

Abbvie Stock Price Rose After the Company and Lilly Pulled Out of a Medicine Pricing Agreement in the UK

Abbvie Stock Price Rose After the Company and Lilly Pulled Out of a Medicine Pricing Agreement in the UK

January 16, 2023

Moderna Stock Drops as Secures Ebola Vaccine Contract With the U.S

Moderna Stock Drops as Secures Ebola Vaccine Contract With the U.S

January 11, 2023

Pfizer Stock Slightly Drops as It Confirms It Isn’t in Talks With the Chinese Government on Generic Paxlovid, Reuters

Pfizer Stock Slightly Drops as It Confirms It Isn’t in Talks With the Chinese Government on Generic Paxlovid, Reuters

January 11, 2023

Moderna Stock Rises on Positive Business Outlook

Moderna Stock Rises on Positive Business Outlook

January 10, 2023

Moderna Stock Surged as It Expects COVID Vaccine Sales of $5 Billion in 2023, Down From $18 Billion in 2022

Moderna Stock Surged as It Expects COVID Vaccine Sales of $5 Billion in 2023, Down From $18 Billion in 2022

January 9, 2023

Pfizer Stock up as China Negotiates License for the COVID Medication Paxlovid

Pfizer Stock up as China Negotiates License for the COVID Medication Paxlovid

January 6, 2023

AbbVie stock up in wake of partnership with Immunome

AbbVie stock up in wake of partnership with Immunome

January 6, 2023

Analysts Believe That Biogen Stock Fell Due to the Rapid Approval of Lecanemab

Analysts Believe That Biogen Stock Fell Due to the Rapid Approval of Lecanemab

January 5, 2023

Merck Stock Was Upgraded to Buy at BOFA Despite the Risk Associated With Keytruda

Merck Stock Was Upgraded to Buy at BOFA Despite the Risk Associated With Keytruda

January 4, 2023

« 1 2 3 4 5 6 … 17 »